Related Experiment Video

Updated: Sep 15, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Role of 'atypical' pneumonia pathogens in respiratory tract infections

J S Tan1

  • 1Section of Infectious Disease, Department of Internal Medicine, Northeastern Ohio Universities College of Medicine, Rootstown, USA. jst@neoucom.edu

Canadian Respiratory Journal
|April 15, 1999
PubMed

Insights

Atypical pathogens like Mycoplasma pneumoniae and Chlamydia pneumoniae cause significant pneumonia cases. Diagnosis is challenging due to difficult culturing and reliance on antibody testing, often leading to empirical treatment.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Atypical pathogens are significant causes of pneumonia, ranging in severity.
  • Common examples include Mycoplasma pneumoniae and Chlamydia pneumoniae, alongside Legionella species and various viruses.

Purpose of the Study:

  • To highlight the challenges in diagnosing and managing atypical pneumonia.
  • To discuss the limitations of current diagnostic methods and the prevalence of empirical treatment.

Main Methods:

  • The abstract discusses the difficulties in determining infection rates due to inconsistent diagnostic testing.
  • It reviews current diagnostic approaches, including acute antibody titers and paired serology.
  • It mentions the limitations of culturing these pathogens.

Main Results:

  • Infection rates for Chlamydia pneumoniae and Mycoplasma pneumoniae are reported up to 8% and 15-20% of pneumonia cases, respectively.
  • Current diagnostic methods are time-consuming or lack accuracy.
  • Empirical treatment remains the primary management strategy.

Conclusions:

  • Accurate and rapid diagnosis of atypical pneumonia remains a significant clinical challenge.
  • The reliance on empirical treatment underscores the need for improved diagnostic tools.
  • Further advancements in diagnostic technologies, such as PCR, are needed for better patient outcomes.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...